USPTO serial 79104404
SITETROVE
Reviewed by CopyMark Law Group
Reg. 4333237Status 706Registered
- Filing date
- Status date
- Registration date
- May 14, 2013
- Examiner
- MORRIS, KRISTINA KLOIBER
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with SITETROVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William C. Wright
William C. Wright Epstein Drangel LLP60 East 42nd Street, Suite 1250New York, NY 10165UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | [ Apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, prerecorded magnetic data carriers featuring information and data in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; blank recording optical discs; pre-recorded CDs, video tapes, laser disks and DVDs featuring information in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare and manuals in electronic format sold as a unit; computer software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; computer software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; downloadable electronic publications in the nature of newsletters, reports, directories and bulletins in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare from databases or the internet; computer programs and computer programs that implement programming languages in electronic form for use in database management in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; prerecorded magnetic, electronic or optical data carriers featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; electronic publications, namely, instruction manuals recorded on computer media relating to use of computers and to data, all recorded magnetically, optically or electronically; magnetic, optical and electronic data recording apparatus for recording of sound, images or data ] | SECTION 71 - CANCELLED | — |
| 041 | [ Education services, namely, providing educational seminars, conferences, classes and workshops in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Training services in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Arranging and conducting of recreation, entertainment, cultural, training and educational conferences, courses, seminars and exhibitions in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; Publishing and issuing of scientific papers in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; ] Electronic publishing services, namely, publication of text [ and graphic works ] of others online featuring information on medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; [ the provision of news online in the nature of news agencies, namely, gathering and dissemination of news; Non-downloadable electronic publications in the nature of journals, newsletters, reports , and directories in the fields of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare via the Internet; ] providing information and consultation services in connection with the above-mentioned services | ACTIVE | — |
| 042 | Industrial analysis and research services in the field of medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; provision of information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services; provision of online information relating to medical research, clinical trials, pharmaceutical research and development, and pharmaceutical drug development services [ ; design and development of computer software, being software for the provision of information relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare; design and development of computer software, being software for the analysis of information and data relating to medical research, clinical trials, pharmaceutical research and development, pharmaceutical drug development services, and healthcare ; technological consultancy and advisory services in the field of computer hardware and software; computer software design services; technological consultancy, design, testing, research and advisory services, all relating to computing and computer programming; website design services; computer programming; computer systems analysis; computer software design; hosting of websites; hosting of digital content, namely, online journals and blogs; technological consultancy and advisory services in the field of computer networks; technical support services relating to computer hardware, computer software, computer networks and the Internet, namely, troubleshooting in the nature of diagnosing problems relating to computer hardware, computer software, computer networks and the Internet; computer network design for others, namely, on-line services for the search, retrieval, indexing and organisation of data on electronic communication networks and for enhancing the performance and function of such networks; database design and development; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services relating to all the aforesaid services provided on-line ] | ACTIVE | — |
| 044 | [ Medical services; advisory medical services and the provision of medical information; dentistry services; advisory services and the provision of information relating to dentistry; advisory services and the provision of information relating to health; consultation in the nature of health risk assessments for medical diagnostic purposes; ] providing medical information, consultancy and advisory services in the field of pharmaceuticals; medical information in the field of pharmaceuticals [; dispensing of pharmaceuticals; veterinary services; medical testing services for diagnostic and treatment purposes; surgical treatment services; advisory services and the provision of medical information relating to surgery; advisory services and the provision of medical information relating to cosmetic surgery; advisory services and the provision of medical information relating to cosmetic treatment; hygienic and beauty care for human beings; hygienic and beauty care for animals; beauty therapy services, namely, medical, hygienic and beauty care services; information, consultancy and advisory services relating to all the aforesaid services; information, consultancy and advisory services relating to all the aforesaid services provided on-line ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharma Intelligence U.K. Limited
- Other trademarks owned by Informa UK Limited
- Other trademarks owned by Informa UK Limited
- Other trademarks owned by Informa UK Limited
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SITETROVE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 27, 2025 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 12, 2025 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 12, 2025 | INPC | INVALIDATION PROCESSED | — |
| Apr 27, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 4, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 27, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 27, 2024 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jul 30, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 10, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jul 29, 2023 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 14, 2022 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Nov 14, 2021 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 1, 2021 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 1, 2021 | INPC | INVALIDATION PROCESSED | — |
| Sep 22, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 22, 2021 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Feb 13, 2020 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 13, 2019 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jun 13, 2019 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| May 16, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 13, 2019 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| May 14, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 8, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 30, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 15, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 15, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 14, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 14, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 5, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 1, 2013 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 26, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 26, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 6, 2013 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 6, 2013 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 6, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 22, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 18, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jan 4, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 17, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 17, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 17, 2012 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 17, 2012 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Nov 17, 2012 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Nov 17, 2012 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Oct 31, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 31, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 31, 2012 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 29, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jun 18, 2012 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 18, 2012 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 18, 2012 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 25, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 25, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 25, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 25, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 25, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 24, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 28, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 28, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 26, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 25, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 22, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 18, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 18, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 17, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |